NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Bariatric Surgery and Pharmacokinetics of Losartan

NCT03519893

RecruitingN/A

Sponsor: Norwegian University of Science and Technology

Conditions: Obesity, Morbid

Interventions: Losartan

Countries: Norway

Changes to gastric pH, gastric emptying time, gastrointestinal transit-time or the pre-systemic metabolizing effect of enzymes secreted in the mucosa may all alter the pharmacokinetics of medicines. These factors are potentially influenced by bariatric surgery. Little is so far known about how gastric bypass and sleeve gastrectomy impacts the biological availability of medication. In this study the pharmacokinetic effects of bariatric surgery on losartan are investigated.

Eligibility overview

Sex: ALL

Age: 18 Years to 70 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Preparing to undergo gastric bypass or sleeve gastrectomy in Central Norway
* Being a Norwegian citizen

Exclusion Criteria:

* Having previously undergone resections in the GI-tract

Locations (1)

Trondheim, Norway